reports
LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025
LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025 BURLINGTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2025 financial results on Thursday, May 1, 2025, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online . All registrants will receive dial-in information and a PIN allowing them to access the live call. The a...
LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conf...
LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference BURLINGTON, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will present at the 24th Annual Needham Virtual Healthcare Conference on Tuesday, April 8, 2025, at 3:45 PM EDT. About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular d...
LeMaitre to Participate at Upcoming Investor Conferences in March
LeMaitre to Participate at Upcoming Investor Conferences in March BURLINGTON, Mass., March 03, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in March. 37th Annual ROTH ConferenceMonday, March 17, 2025The Laguna Cliffs Marriott, Dana Point, CAManagement will present at 4:00 PM PDT KeyBanc Healthcare ForumWednesday, March 19, 2025Virtual EventManagement will present at 1:30 PM EDT Oppenheimer 35th Annual Healthcare MedTech & Services ConferenceThursday, March 20, 2025Virtua...
LeMaitre Q4 2024 Financial Results
LeMaitre Q4 2024 Financial Results BURLINGTON, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants, and services, reported Q4 2024 results, announced an increased quarterly dividend of $0.20/share (+25%), and provided guidance. Q4 2024 Financial Results Sales $55.7mm, +14% (+14% organic) vs. Q4 2023Gross margin 69.3%, +121 bpsOp. income $12.9mm, +26%Op. margin 23%Earnings per diluted share $0.49, +30%Cash up $175.8mm sequentially to $299.7mm Grafts (+23%), carotid shunts (+14%) and catheters (+12%) drove Q4 sales growth. APAC ...
LeMaitre Will Announce Fourth Quarter 2024 Earnings Results February 2...
LeMaitre Will Announce Fourth Quarter 2024 Earnings Results February 27, 2025 BURLINGTON, Mass., Jan. 27, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2024 financial results on Thursday, February 27, 2025, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online . All registrants will receive dial-in information and a PIN allowing them to access the liv...
LeMaitre Vascular Prices $150 Million Convertible Senior Notes
LeMaitre Vascular Prices $150 Million Convertible Senior Notes BOSTON, Dec. 16, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (“LeMaitre”) (Nasdaq: LMAT) today announced the pricing of its offering of $150,000,000 aggregate principal amount of 2.50% Convertible Senior Notes due 2030 (the “notes”) in a private offering (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The issuance and sale of the notes is scheduled to settle on December 19, 2024, subject to customary closing conditions. LeMaitre ...
LeMaitre Vascular Announces Proposed Convertible Senior Notes Offering
LeMaitre Vascular Announces Proposed Convertible Senior Notes Offering BOSTON, Dec. 16, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (“LeMaitre”) (Nasdaq: LMAT) today announced its intention to offer, subject to market and other conditions, $150,000,000 aggregate principal amount of Convertible Senior Notes due 2030 (the “notes”) in a private offering (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). LeMaitre also expects to grant the initial purchasers of the notes an option to purchase, for s...
LeMaitre to Participate at Upcoming Investor Conferences in December
LeMaitre to Participate at Upcoming Investor Conferences in December BURLINGTON, Mass., Nov. 25, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences in December. David Roberts, President, will present at the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024, at the Lotte New York Palace in New York City. The company’s presentation is scheduled for 3:30 PM EST. He is also scheduled to present at the Stifel “MedTech Madness” West Coast Bus Tour at the Rosewood Sand Hill ...
LeMaitre to Participate at Upcoming Investor Conferences in November
LeMaitre to Participate at Upcoming Investor Conferences in November BURLINGTON, Mass., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in November. UBS Global Healthcare Conference Wednesday, November 13, 2024 Terranea Resort, Rancho Palos Verdes, CA David Roberts, President, will present at 7:15 AM PT Stifel's 2024 Healthcare Conference Tuesday, November 19, 2024 Lotte NY Palace Hotel, New York City David Roberts, President, will pr...
LeMaitre Q3 2024 Financial Results
LeMaitre Q3 2024 Financial Results BURLINGTON, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants, and services, reported Q3 2024 results, announced a $0.16/share quarterly dividend, and provided guidance. Q3 2024 Financial Results Sales $54.8mm, +16% (+16% organic) vs. Q3 2023Gross margin 67.8%, +280 bpsOp. income $13.1mm, +43%Op. margin 24%Earnings per diluted share $0.49, +46%Cash up $10.8mm sequentially to $123.9mm Grafts (+24%), patches (+13%) and carotid shunts (+18%) drove Q3 sales growth. APAC sales increased 24%, EMEA 22% ...
LeMaitre Will Announce Third Quarter 2024 Earnings Results October 31,...
LeMaitre Will Announce Third Quarter 2024 Earnings Results October 31, 2024 BURLINGTON, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2024 financial results on Thursday, October 31, 2024, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online . All registrants will receive dial-in information and a PIN allowing them to access the live cal...
LeMaitre to Participate at Upcoming Investor Conferences in September
LeMaitre to Participate at Upcoming Investor Conferences in September BURLINGTON, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in September. Morgan Stanley 22nd Annual Global Healthcare ConferenceWednesday, September 4, 2024New York Marriott Marquis, New York, NYDavid Roberts, President, will present at 5:35 PM EST Barrington Research Fall Investment Conference (Virtual)Thursday, September 12, 2024George W. LeMaitre, Chairman & CEO, is scheduled to host a series...
LeMaitre Q2 2024 Financial Results
LeMaitre Q2 2024 Financial Results BURLINGTON, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2024 results, announced a $0.16/share quarterly dividend and provided guidance. Q2 2024 Financial Results Sales $55.8mm, +11% (+12% organic) vs. Q2 2023 Gross margin 68.9%, +490 bpsOp. income $14.4mm, +52%Op. margin 26%Net income $11.8mm, +46%Earnings per diluted share $0.52, +44%Cash up $4.8mm sequentially to $113.1mm Allografts (+30%), bovine patches (+12%) and carotid shunts (+22%) led Q2 sales growt...
LeMaitre Will Announce Second Quarter 2024 Earnings Results August 1, ...
LeMaitre Will Announce Second Quarter 2024 Earnings Results August 1, 2024 BURLINGTON, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2024 financial results on Thursday, August 1, 2024, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online . All registrants will receive dial-in information and a PIN allowing them to access the live call....
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
URI UNITED RENTALS INC.
SIX SIX FLAGS ENTERTAINMENT CORPORATION
FTH SILESIA ONE SA
WWW WOLVERINE WORLD WIDE INC.
WING WINGSTOP INC.
NVDA NVIDIA CORPORATION
MU MICRON TECHNOLOGY INC.
MPWR MONOLITHIC POWER SYSTEMS INC.
LOCO EL POLLO LOCO HOLDINGS INC
LMAT LEMAITRE VASCULAR INC.
LAKE LAKELAND INDUSTRIES INC.
GPRK GEOPARK
GLW CORNING INC
FUN CEDAR FAIR L.P.
CNK CINEMARK HOLDINGS INC.
BPMC BLUEPRINT MEDICINES CORP.
AOSL ALPHA & OMEGA SEMICONDUCTOR
EGY VAALCO ENERGY INC.
MEG. MEG ENERGY CORP.
CW CURTISS-WRIGHT CORPORATION
LZB LAZBOY INCORPORATED
CAH CARDINAL HEALTH INC.
FI FRANK'S INTERNATIONAL NV
NSA NATIONAL STORAGE AFFILIATES TRUST
ELF E.L.F. BEAUTY INC.
AMKR AMKOR TECHNOLOGY INC.
DELL DELL TECHNOLOGIES INC CLASS C
TWST TWIST BIOSCIENCE
DYN DYNE THERAPEUTICS
VRT VERTIV HOLDINGS CO (A)
SG SWEETGREEN INC
FTAI ONTO INNOVATION INC.
RDW FORTRESS TRANSN & INFRAS INVS LLC
2VZ REDWIRE CORP
FIP LEONARDO DRS INC.
FTAI INFRASTRUCTURE INC
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
ROL ROLLINS INC.
PSIX POWER SOLUTIONS INTERNATIONAL INC.
OLLI OLLIE'S BARGAIN OUTLET HOLDINGS INC
LMAT LEMAITRE VASCULAR INC.
IRT INDEPENDENCE REALTY TRUST INC.
HAS HASBRO INC.
ESS ESSEX PROPERTY TRUST INC.
CDNS CADENCE DESIGN SYSTEMS INC.
ADBE ADOBE INC.
NFLX NETFLIX INC.
TTC TORO COMPANY
USM UNITED STATES CELLULAR CORP
USLM U.S. LIME & MINERALS
URGN UROGEN PHARMA
AVGO BROADCOM INC.
SPOT SPOTIFY TECHNOLOGY SA
FRHC FREEDOM HOLDING CORP
DCTH DELCATH SYSTEMS
TERN TERNS PHARMACEUTICALS
SMMT SUMMIT THERAPEUTICS INC
MEG MONTROSE ENVIRONMENTAL GROUP
ALHC ALIGNMENT HEALTHCARE INC
MITT AG MORTGAGE INVESTMENT TRUST INC
APP APPLOVIN CORP
ASTS AST SPACEMOBILE INC
NU NU HLDGS LTD
BRCC BRC INC
NGNE NEUROGENE INC
AKA AKA BRANDS HOLDING CORP
INST INSTRUCTURE HLDGS INC
SYRS SYROS PHARMACEUTICALS INC.
AUID AUTHID INC
NLCP NEWLAKE CAPITAL PARTNERS INC COM
LeMaitre to Present at the Jefferies Global Healthcare Conference
LeMaitre to Present at the Jefferies Global Healthcare Conference BURLINGTON, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that George W. LeMaitre, Chairman & CEO, will present at the 2024 Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 11:00 AM ET at the Marriott Marquis in New York City. About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and ma...
LeMaitre Q1 2024 Financial Results
LeMaitre Q1 2024 Financial Results BURLINGTON, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2024 results, announced a $0.16/share quarterly dividend and provided guidance. Q1 2024 Financial Results Sales $53.5mm, +14% (+11% organic) vs. Q1 2023 Gross margin 68.6%, +300 bpsOp. income $11.9mm, +51%Op. margin 22%Net income $9.9mm, +64%Earnings per diluted share $0.44, +62%Cash up $3.2mm sequentially to $108.3mm Allografts (+31%), bovine patches (+13%), carotid shunts (+27%) and distributed porcine...
LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024
LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024 BURLINGTON, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2024 financial results on Thursday, May 2, 2024, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online . All registrants will receive dial-in information and a PIN allowing them to access the live call. The au...
LeMaitre to Present at the 23rd Annual Needham Virtual Healthcare Conf...
LeMaitre to Present at the 23rd Annual Needham Virtual Healthcare Conference BURLINGTON, Mass., March 26, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present virtually at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10, 2024, at 11:30 AM ET. About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets dis...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.